Upload
vuongthien
View
219
Download
0
Embed Size (px)
Citation preview
2. Februar 2017 Krankenversicherung und Leistungsanbieter 1
Reinhard Busse, Prof. Dr. med. MPH FFPHFG Management im Gesundheitswesen, Technische Universität Berlin
(WHO Collaborating Centre for Health Systems Research and Management)&
European Observatory on Health Systems and Policies
DRG Systeme in Europa
Management im GesundheitswesenKrankenversicherung und Leistungsanbieter
Paymentmecha-
nism
Patient needs (risk
selection)
ActivityExpendi-
turecontrol
Technical efficiency
Trans-parency
QualityAdmini-strative
simplicityNumber of services/
case
Number of
cases
Fee-for-service + + + ― 0 0 0 ―
DRG based case payment
0 ― + 0 + + 0 ―
Global budget ― ― ― + 0 ― 0 +
Incentives ofdifferent forms of hospital payment
2Krankenversicherung und Leistungsanbieter2. Februar 2017
Paymentmecha-
nism
Patient needs (risk
selection)
ActivityExpendi-
turecontrol
Technical efficiency
Trans-parency
QualityAdmini-strative
simplicityNumber of services/
case
Number of
cases
Fee-for-service + + + ― 0 0 0 ―
DRG based case payment
0 ― + 0 + + 0 ―
Global budget ― ― ― + 0 ― 0 +
Incentives ofdifferent forms of hospital payment
European
countries 1990s/2000s
USA 1980s
“dumping” (avoidance), “creaming”
(selection) and “skimping” (undertreatment)
up/wrong-coding, gaming
3Krankenversicherung und Leistungsanbieter2. Februar 2017
Country Study Activity ALoS
US, 1983 US Congress - Office of
Technology Assessment, 1985
▼ ▼
Guterman et al., 1988 ▼ ▼
Davis and Rhodes, 1988 ▼ ▼
Kahn et al., 1990 ▼
Manton et al., 1993 ▼ ▼
Muller, 1993 ▼ ▼
Rosenberg and Browne, 2001 ▼ ▼
Empirical evidence (I): hospital activity and length-of-stay under DRGs
USA
1980s
4Krankenversicherung und Leistungsanbieter2. Februar 2017
Cf. Table 7.4 in Busse et al. 2011
European
countries
1990/ 2000s
Empirical evidence (II)
2. Februar 2017
Country Study Activity ALoS
Sweden,
early 1990s
Anell, 2005 ▲ ▼
Kastberg and Siverbo, 2007 ▲ ▼
Italy, 1995 Louis et al., 1999 ▼ ▼
Ettelt et al., 2006 ▲
Spain, 1996 Ellis/ Vidal-Fernández, 2007 ▲
Norway,
1997
Biørn et al., 2003 ▲
Kjerstad, 2003 ▲
Hagen et al., 2006 ▲
Magnussen et al., 2007 ▲
Austria, 1997 Theurl and Winner, 2007 ▼
Denmark, 2002 Street et al., 2007 ▲
Germany, 2003 Böcking et al., 2005 ▲ ▼
Schreyögg et al., 2005 ▼
Hensen et al., 2008 ▲ ▼
England,
2003/4
Farrar et al., 2007 ▲ ▼
Audit Commission, 2008 ▲ ▼
Farrar et al., 2009 ▲ ▼
France, 2004/5 Or, 2009 ▲ 5
Cf. Table 7.4
in Busse
et al. 2011
To get a common “currency” of hospital activity for
• transparency efficiency benchmarking &
performance measurement (protect/ improve quality),
• budget allocation (or division among providers),
• planning of capacities,
• payment ( efficiency)
Exact reasons, expectations and DRG usage differ
among countries – due to (de)centralisation, one
vs. multiple payers, public vs. mixed ownership.
6Krankenversicherung und Leistungsanbieter2. Februar 2017
Reasons for DRGs:
Timeline and purposes of introduction
7
Country
19
80
19
85
19
90
19
95
20
00
20
05
20
10
Original purpose Principal purpose in 2010
Austria Budgetary allocation Budgetary allocation, Planning
England Measuring hospital activity Payment
Estonia Payment Payment
FinlandMeasuring hospital activity, benchmarking
Planning, benchmarking, hospital billing
France Measuring hospital activity Payment
Germany Payment Payment
Ireland Budgetary allocation Budgetary allocation
Netherlands Payment Payment
Poland Payment Payment
Portugal Measuring hospital activity Budgetary allocation
Spain (Catalonia)
Payment Payment, benchmarking
Sweden PaymentMeasuring hospital activity, benchmarking
19
80
19
85
19
90
19
95
20
00
20
05
20
10
Introduction of DRGs
DRG-based hospital payment
Krankenversicherung und Leistungsanbieter2. Februar 2017
DRG-based case payments, DRG-based budget allocation
(possibly adjusted for outliers, quality etc.)
Excluded costs(e.g. for infrastructure; in U.S. also physician services)
Payments for non-patient care activities(e.g. teaching, research, emergency availability)
Payments for patients not classified into DRG system(e.g. outpatients, day cases, psychiatry, rehabilitation)
Other types of payments for DRG-classified patients(e.g. global budgets, fee-for-service)
Additional payments for specific activities for DRG-classified patients (e.g. expensive drugs, innovations),
possibly listed in DRG catalogues
For what types of activities? Scope of DRGs (I)
Krankenversicherung und Leistungsanbieter 82. Februar 2017
Psychiatry Day casesAcute
inpatient careOutpatient care Rehabilitation
Original DRG
systems
DRG system(included in orseparate fromoriginal DRGs)
DRG system(included in orseparate fromoriginalDRGs)
DRG system(identical ordifferent to
original DRGs)
DRG system(included in orseparate fromoriginal DRGs)
For what types of activities? Scope of DRGs (II)
Krankenversicherung und Leistungsanbieter 92. Februar 2017
Scope in the Netherlands: DBCs (diagnosis-treatment combinations); examples
Inpatient acute care incl. ICU
Ambulatory
specialist
care
Hospitalisation
Discharge
DBC 1
DBC 2
DBC 3
DBC 6
DBC 5
Ambulatory specialist
care
DBC 4
10Krankenversicherung und Leistungsanbieter2. Februar 2017
Patient classification system
Data collection
Price setting
Actual reimbursement
• Diagnoses• Procedures
• Severity• Frequency of revisions
• Demographic data
• Clinical data
• Cost data
• Sample size, regularity
• Cost weights
• Base rate(s)• Prices/ tariffs
• Average vs. “best”
• Volume limits
• Outliers• High cost cases
• Quality• Innovations
• Negotiations
Essential building blocks of DRG systems
Import 1
2
34
11Krankenversicherung und Leistungsanbieter2. Februar 2017
AP-DRG AR-DRG G-DRG GHM NordDRG HRG JGP LKF DBC
DRGs / DRG-like groups 679 665 1,200 2,297 794 1,389 518 979 ≈30,000
MDCs / Chapters 25 24 26 28 28 23 16 - -
Partitions 2 3 3 4 2 2* 2* 2* -
Basic characteristics of DRG-like PCS in Europe
Patient classification system
• Diagnoses
• Procedures
• Severity
• Frequency of revisions
12Krankenversicherung und Leistungsanbieter2. Februar 2017
Main questions relating to data collection
Clinical data
classification system for diagnoses and
classification system for procedures
Cost data
imported (not good but easy) or
collected within country (better but needs
standardised cost accounting)
Sample size
entire patient population or
a smaller sample
Many countries: clinical data = all patients;
cost data = hospital sample
with standardised cost accounting system
Data collection
• Demographic data• Clinical data
• Cost data
• Sample size, regularity
13Krankenversicherung und Leistungsanbieter2. Februar 2017
Diagnosis and procedure coding across Europe
Country Diagnosis Coding Procedure Coding
Austria ICD-10-AT Leistungskatalog
England ICD-10 OPCS - Office of Population Censuses and Surveys
Estonia ICD-10 NCSP - Nomesco Classification of Surgical Procedures
Finland ICD-10 NCSP - Nomesco Classification of Surgical Procedures
France ICD-10 CCAM - Classification Commune des Actes Médicaux
Germany ICD-10-GM OPS - Operationen- und Prozedurenschlüssel
Ireland ICD-10-AM ACHI - Australian Classification of Health Interventions
The Netherlands ICD-10 Elektronische DBC Typeringslijst
Poland ICD-10 ICD-9-CM
Portugal ICD-9-CM ICD-9-CM
Spain ICD-9-CM ICD-9-CM
Sweden ICD-10 NCSP - Nomesco Classification of Surgical Procedures
(almost)
standardisedno uniform standard available
14Krankenversicherung und Leistungsanbieter
Data collection
• Demographic data
• Clinical data
• Cost data
• Sample size, regularity
2. Februar 2017
Number (share) of costdata collecting hospitals
Direct costallocation to patients
Data used for calculation of DRG weights
Austria20 reference hospitals (~8% of all hospitals)
grosscosting x
England all hospitals top down microcosting x
EstoniaAll hospitals contracted by
the NHIFtop down microcosting x
Finland5 reference hospitals
(~30% of specialised care)bottom up microcosting x
France99 hospitals (~ 13% of inpatient admissions)
mainly top down microcosting
x
Germany~250 hospitals
(~ 15% of all hospitals) mainly bottom up
microcostingx
Ireland
Imported DRG systems and weights (or with only minor modifications)Poland
Portugal
The Netherlandsunit costs: 15-25 hospitals
(~ 24% of all hospitals)bottom up microcosting x
Spain Imported DRG systems and weights
Sweden(~ 62% of inpatient
admissions)bottom up microcosting x
15
Collection of cost dataData collection
• Demographic data
• Clinical data
• Cost data
• Sample size, regularity
Krankenversicherung und Leistungsanbieter2. Februar 2017
“cost weight“ (varies by DRG)
“base rate“ or adjustment
Relative weight(e.g. Germany)
1.0€ 3000 (+/-)
(varies slightly by state)
Raw tariff(e.g. France)
€ 30001.0 (+/-)
(varies by region and hospital)
Raw tariff(e.g. England)
£ 30001.0 – 1.32
(varies by hospital)
Score (e.g. Austria) 130 points € 30
X
X
X
Price setting
• Cost weights
• Base rate(s)
• Prices/ tariffs
• Average vs. “best”
How to calculate costs and set prices fairly (I)
16Krankenversicherung und Leistungsanbieter2. Februar 2017
X
• Based on good quality data
(not possible if cost weights imported)
• “Cost weights x base rate”
vs. “Tariff + adjustment” vs. Scores (see below)
• Average costs vs. “best practice” (for few HRGs in England)
17
Country Monetary conversion/
adjustment factors
Applicability of conversion
rate / adjustment factors
Austria (Implicit) Point value Depending on state
England Market forces factor Hospital-specific
Estonia Base rate Nationwide
Finland Base rate Hospital-specific
France (1) Regional adjustment
(2) Transition coefficient (until
2012)
(1) Region-specific
(2) Hospital-specific
Germany Base rate State-wide
Ireland Base rates (1) Specific to one of four hospital
peer groups
(2) Hospital-specific
Netherlands Direct (no conversion) Not applicable
Poland Point value Nationwide
Portugal Base rate Hospital peer group
Spain (Catalonia) (1) Direct (no conversion)
(2) Base rate
(1) Not applicable
(2) Region-wide (CMS-DRGs)
Sweden Base rate County-specific
How to calculate costs and set prices fairly (II)
Price setting
• Cost weights
• Base rate(s)
• Prices/ tariffs
• Average vs. “best”
Krankenversicherung und Leistungsanbieter2. Februar 2017
18
How many patient records did we use?
Busse R et al. BMJ 2013Krankenversicherung und Leistungsanbieter2. Februar 2017
19
How many DRGs exist per episode?
Busse R et al. BMJ 2013Krankenversicherung und Leistungsanbieter2. Februar 2017
20
How wide is the price variation?
Busse R et al. BMJ 2013Krankenversicherung und Leistungsanbieter2. Februar 2017
21
Size of bubble:
number of DRGs
Range:
DRG weights
(index case = 1)
14x
28x
2x
2.5x 2.5x
1x
1.1x 1.5x
60x
30x
1.5x
1.7x
5x
3.4x
16 10
14
10
10 10
Busse R et al. BMJ 2013
2. Februar 2017 Krankenversicherung und Leistungsanbieter
Krankenversicherung und Leistungsanbieter 22
To become even more specific, definition of AMI index case and 6 other vignettes
1 & 2:
not invasive
(1 = death)
3 - 6:
invasive
(3 & 5 = BMS,
4 & 6 = DES,
6 = death)
Quentin W et al. Eur Heart J 2013
2. Februar 2017
23
€ 2601 € 4533
€ 2189 € 1837
€ 2926 € 7933
AMI: relative DRG payments I (index case = 1)
16% receive stents
57% receive stents
Qu
enti
n W
et
al. E
ur
Hea
rt J
20
13
Krankenversicherung und Leistungsanbieter2. Februar 2017
25
Stroke episode:index case & six case vignettes
Peltola M & Quentin W Cerebrovasc Dis 2013
Krankenversicherung und Leistungsanbieter2. Februar 2017
26
Stroke episode: classification criteria
Candidates:
• Age
• Primary diagnosis (stroke or infarction vs. bleeding …)
• Secondary diagnoses/ comorbidities/ complications
• Procedures (e.g. systemic thromboloysis)
• Death/ time of death
• Length-of-stay
• Use of stroke unit
Krankenversicherung und Leistungsanbieter2. Februar 2017
2. Februar 2017 27
Stroke episode: classification criteria
ENG
EST
GER
Krankenversicherung und Leistungsanbieter
28
Stroke episode: resulting reimbursement
Thrombolysis
& >7 daysStroke
unit
Day care
Secondary
diagnoses
Thrombo-
lysis
Secondary
diagnoses
Death
Peltola M & Quentin W Cerebrovasc Dis 2013
Krankenversicherung und Leistungsanbieter2. Februar 2017
2. Februar 2017 Krankenversicherung und Leistungsanbieter 29
Incentives of DRG-based
hospital payment
Strategies of hospitals
1. Reduce costs per
patient
a) Reduce length of stay
optimize internal care pathways
inappropriate early discharge (‘bloody discharge’)
b) Reduce intensity of provided services
avoid delivering unnecessary services
withhold necessary services (‘skimping/undertreatment’)
c) Select patients
specialize in treating patients for which the hospital has a competitive
advantage
select low-cost patients within DRGs (‘cream-skimming’)
2. Increase revenue per
patient
a) Change coding practice
improve coding of diagnoses and procedures
fraudulent reclassification of patients, e.g. by adding inexistent
secondary diagnoses (‘up-coding’)
b) Change practice patterns
provide services that lead to reclassification of patients into higher
paying DRGs (‘gaming/overtreatment’)
3. Increase number of
patients
a) Change admission rules
reduce waiting list
admit patients for unnecessary services (‘supplier-induced demand’)
b) Improve reputation of hospital
improve quality of services
focus efforts exclusively on measurable areas
Being aware of incentives and hospital strategies
How European DRG systems reduce unintended behaviour: 1. long- and short-stay adjustments
LOS
Revenues
Deductions(per day)
Surcharges(per day)
Short-stay outliers
Long-stay outliers
Inliers
Lower LOSthreshold
Upper LOSthreshold
Actual reimbursement
• Volume limits
• Outliers• High cost cases
• Quality• Innovations
• Negotiations
30Krankenversicherung und Leistungsanbieter2. Februar 2017
How European DRG systems reduce unintended behaviour: 2. Fee-for-service-type additional payments
Actual reimbursement
• Volume limits
• Outliers• High cost cases
• Quality• Innovations
• Negotiations
England France Germany Nether-lands
Payments per hospital stay
One One One Several possible
Payments for specific high-cost services
Unbundled HRGs for e.g.:• Chemotherapy•Radiotherapy•Renal dialysis•Diagnostic imaging•High-cost drugs
Séances GHM for e.g.:• Chemotherapy•Radiotherapy•Renal dialysis
Additional payments:• ICU• Emergency care• High-cost drugs
Supplementary payments for e.g.:• Chemotherapy•Radiotherapy•Renal dialysis•Diagnostic imaging•High-cost drugs
No
Innovation-related add’lpayments
Yes Yes Yes Yes (for drugs)
31Krankenversicherung und Leistungsanbieter2. Februar 2017
Type of
adjustmentMechanism Examples
Hospital
based
DRG/
disease
based
Patient
based
Payment for an individual patient is
adjusted upwards or downwards by a
certain amount
No payment is made for a case
Certain readmissions within 30 days are not paid
separately but as part of the original admission (e.g., in
England and Germany)
Complications (that is, certain conditions that were not
present upon admission) cannot be used to classify
patients into DRGs that are weighted more heavily (e.g.,
in the United States)
How DRG systems reduce unintendedbehaviour: 3. adjustments for quality
32Krankenversicherung und Leistungsanbieter2. Februar 2017
Type of
adjustmentMechanism Examples
Hospital
based
DRG/
disease
based
Payment for all patients with a certain
DRG (or a disease entity) is adjusted
upwards or downwards by a certain
percentage
DRG payment is not based on average
costs but is awarded to those hospitals
delivering ‘good quality’
Insurers negotiate with hospitals that DRG payment is
higher/lower if certain quality standards are met/not met
(e.g., in Germany and the Netherlands)
DRG payment for all hospitals is based on ‘best practice’;
that is, costs incurred by efficient, high-quality hospitals
(e.g., in England)
Patient
based
Payment for an individual patient is
adjusted upwards or downwards by a
certain amount
No payment is made for a case
Certain readmissions within 30 days are not paid
separately but as part of the original admission (e.g., in
England and Germany)
Complications (that is, certain conditions that were not
present upon admission) cannot be used to classify
patients into DRGs that are weighted more heavily (e.g.,
in the United States)
Type of
adjustmentMechanism Examples
Hospital
based
Payment for entire hospital activity is
adjusted upwards or downwards by a
certain percentage
Hospital receives an additional
payment unrelated to activity
Predefined quality results are met/not met (e.g., in
England)
Overall readmission rate is below/above average or
below/above agreed target (e.g., in the United States)
Hospitals install new quality improvement measures (e.g.,
in France)
DRG/
disease
based
Payment for all patients with a certain
DRG (or a disease entity) is adjusted
upwards or downwards by a certain
percentage
DRG payment is not based on average
costs but is awarded to those hospitals
delivering ‘good quality’
Insurers negotiate with hospitals that DRG payment is
higher/lower if certain quality standards are met/not met
(e.g., in Germany and the Netherlands)
DRG payment for all hospitals is based on ‘best practice’;
that is, costs incurred by efficient, high-quality hospitals
(e.g., in England)
Patient
based
Payment for an individual patient is
adjusted upwards or downwards by a
certain amount
No payment is made for a case
Certain readmissions within 30 days are not paid
separately but as part of the original admission (e.g., in
England and Germany)
Complications (that is, certain conditions that were not
present upon admission) cannot be used to classify
patients into DRGs that are weighted more heavily (e.g.,
in the United States)
4. Frequent revisions of PCS and payment rates
33Krankenversicherung und Leistungsanbieter2. Februar 2017
Country PCS Payment rate
Frequency of updates Time-lag to data Frequency of updates Time-lag to data
Austria Annual 2–4 years 4–5 years 2–4 years
England Annual Minor revisions annually; irregular
overhauls about every 5–6 years
Annual 3 years (but adjusted
for inflation)
Estonia Irregular (first
update after 7 years)
1–2 years Annual 1–2 years
Finland Annual 1 year Annual 0–1 year
France Annual 1 year Annual 2 years
Germany Annual 2 years Annual 2 years
Ireland Every 4 years Not applicable (imported AR-DRGs) Annual (linked to
Australian updates)
1–2 years
Netherlands Irregular Not standardized Annual or when
considered necessary
2 years, or based on
negotiations
Poland Irregular – planned
twice per year
1 year Annual update only of
base rate
1 year
Portugal Irregular Not applicable (imported AP-DRGs) Irregular 2–3 years
Spain
(Catalonia)
Biennial Not applicable (imported
3-year-old CMS-DRGs)
Annual 2–3 years
Sweden Annual 1–2 years Annual 2 years
2007
2.1
1.3
2.5
2006
0.00.4
1.5
-2.1-1.8
0.3
1.1
2009
1.41.5
2.62.9
2008
1.1
2.3
3.8
2010
-2.0
A-Segment A-Segment corrected for budget reductions B-Segment 2005 B-Segment 2008 B-Segment 2009
Free prices – to be negotiated between insurers and providers
Share %
B-segment
Main
additions
to
B-segment
Knee Arthritis
Cataract
Hip Arthritis
Slipped Disc
Diabetes
Pregnancy Birth
Cataract
Pacemaker
Meniscus
Breast Cancer
Cardio
Stroke
Follow-up Cardio
Skin Cancer
10% 19% 34%
Fixed prices – set by health regulator
Price development hospital DBCs 2006-2010 (%, nominal)
Sources: Marktscan Medisch Specialistische Zorg 2011; Nza. Onderhandelen over ziekenhuiszorg; Vektis 2009
Prices for list B–DBCs in the Netherlandscan be negotiated Actual
reimbursement
• Volume limits
• Outliers
• High cost cases
• Quality
• Innovations
• Negotiations
2. Februar 2017 Krankenversicherung und Leistungsanbieter 34
Health care reform succeeded in lowering prices, but it did not curb volume growth
10
-0.54)
09
0.3
08
5.5
07
1.3
06
1.0
05
-0.9
04
0.1
03
2.1
02
7.4
01
11.0
00
5.3
99
5.6
Volume growth (%)
Generic
Inflation2)
10
4.0
09
6.4
08
5.4
07
4.3
06
3.2
05
4.6
04
6.4
03
4.1
02
5.4
01
2.8
00
0.1
99
0.2
• But since the health
care reform volume
growth accelerated
• Today’s challenge:
volume growth
reduction without the
waiting lists of the
1990s
• Health care reform
(competition) has
indeed led to lower
prices (driven by B-
segment)
The 2005-2006 Reform Paradigm• Volume growth is a fact of life: ageing,
innovation• More efficiency is needed to deal with
volume growth• Competition will lead to more efficiency
and lower prices
Strict
budgeting
Wait list
reduction
Health care reform:
competitions
09 10
3.5
6.8
08
10.9
04
6.5
03
6.2
02
12.9
07
5.6
06
4.1
05
3.7
01
13.8
00
5.4
99
5.8
Price increase (%)Total growth in hospital expenditures (%)1)
1) Hospital expenditure include day and/or night cost and include specialist health care (4) Estimate based on “Marktscan Medisch specialistische zorg2011”2) Consumer Price Index CBSSources: CBS Statline (Zorgrekeningen; expenditures at current and constant cost); RIVM Performance Of Dutch Health Care 2010; Stijging Zorgkostenontrafeld; VGE; Marktscan Medisch specialistische zorg 2011; BoStrategy& analysis
Actual reimbursement
• Volume limits
• Outliers
• High cost cases
• Quality
• Innovations
• Negotiations
2. Februar 2017 Krankenversicherung und Leistungsanbieter 35
Conclusions
• DRG-based hospital payment is the main method of provider payment in Europe, but systems vary across countries– Different patient classification systems
– DRG-based budget allocation vs. case-payment
– Regional/local adjustment of cost weights/conversion rates
• To address potential unintended consequences, countries– implemented DRG systems in a step-wise manner
– operate DRG-based payment together with other payment mechanisms
– refine patient classification systems continously (increase number of groups)
– place a comparatively high weight on procedures
– base payment rates on actual average (or best-practice) costs
– reimburse outliers and and high cost services separately
– update both patient classification and payment rates regularly
• If done right (which is complex), DRGs can contribute to increased transparency and efficiency – and possibly quality
36Krankenversicherung und Leistungsanbieter2. Februar 2017
2. Februar 2017 37Krankenversicherung und Leistungsanbieter